spacer
home > ict > winter 2009 > informed integration
PUBLICATIONS
International Clinical Trials

Informed Integration

The biopharmaceutical industry has benefited substantially in recent years from a wide range of eClinical solutions, including electronic data capture (EDC), interactive voice and web response systems (IVRS/IWRS), clinical trial management systems (CTMS), clinical data management systems (CDMS), medical imaging, lab software and electronic patient reported outcomes (ePRO) solutions. While these technologies have significantly improved efficiency and data quality within specific parts of the clinical development process, there remains throughout the industry a critical need to improve the ability to share information and reduce redundant data entry across the clinical enterprise. This lack of data integration and interoperability is preventing biopharmaceutical companies from reaping even greater rewards from their technology systems, such as improved support for ‘go/no-go’ decisions, greater trial productivity and faster product development.

It is apparent that the adoption of eClinical technologies needs to keep pace with the rapid evolution in the global marketplace of biopharmaceutical products. The industry faces an array of challenges, including mounting pressure to improve product development processes, and bring innovative compounds to market more quickly, significantly higher development costs, and growing regulatory demands, especially the need to increase drug safety.

To improve the productivity and efficiency of clinical trials, biopharmaceutical companies must accelerate their implementation of the next generation of eClinical systems and leverage available technologies to better integrate their trial data. While these technology improvements can present their own challenges, the demands of today’s complex healthcare environment make data integration improvements absolutely vital. With greater strategic access to integrated trial information, biopharmaceutical companies will be able to make better development decisions, eliminate inefficient redundancies, reduce trial delays, improve patient safety and speed up time to market.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
David Stein is Perceptive Informatics’ Senior Director of Product Management and plays a pivotal role in managing the company’s products and services, as well as developing new technology solutions to improve the clinical trials process. Prior to joining Perceptive Informatics in 2002, David worked in Strategic Business Development and Marketing at PhaseForward. He also founded, and later sold, an electronic patient reported outcomes company. Earlier in his career, he established and managed the data management department for a mid-sized contract research organisation. David has also served as an independent consultant in the field of pharmaceutical technologies, and has co-developed several custom software packages.

 

spacer
David Stein
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

White Papers

Clinical Research in Spain

BioClever

This whitepaper is on clinical research in Spain, giving a general outline of the main characteristics of research in this country and an overview of the applicable regulations, along with the reasons why Spain is a good place to do research.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement